MRPL1

Across TCGA pan-cancer cohorts, MRPL1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated MRPL1 data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher MRPL1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated MRPL1 expression acts as an unfavorable survival marker, although some lineages such as LSCC and GBM show a favorable association.

LSCC, PDAC, and GBM are the cancer types where MRPL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Median	II,III,IV	1.000	0.830	.003	11	view →
PDAC	OS	Tertile	IV	0.231	0.973	.024	9	view →
GBM	OS	Median	All	0.869	0.674	.033	6	view →
CCRCC	DFS	Median	III,IV	0.454	0.728	.033	6	view →
LUAD	DFS	Median	All	0.541	0.875	.028	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MRPL1–LSCC (DFS)

Open the LSCC breakdown →